" class="no-js "lang="en-US"> Board of Directors Archives - Medtech Alert
Saturday, June 22, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors

Kallyope, a clinical-stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with […]

Marie Mazur Appointed Chair of PharmaJet Board of Directors

PharmaJet, a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals […]

Visgenx Appoints William Pedranti as Chief Executive Officer

Visgenx, a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced […]

The OSE Immunotherapeutics Board of Directors Proposes the Appointment of Eric Leire, MD, as New Independent Director

OSE Immunotherapeutics, a biotech company dedicated to developing first-in-class assets in immuno-oncology and immuno-inflammation, today […]

Acurex Biosciences Appoints Esteemed Biopharmaceutical Leader Dr. Robert Booth to its Board of Directors

Acurex Biosciences, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces […]

TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors

TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]

FzioMed Announces Addition of Industry Veteran to its Board of Directors

FzioMed, a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, […]

Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors

Prothena, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on […]

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of […]

NeuroBo Pharmaceuticals Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors

NeuroBo Pharmaceuticals, a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more